 |
Conference Summary
Launched in 2000, this FASEB Science Research Conference (SRC) is dedicated to exploring emergent knowledge on rapid and genomic actions of nuclear receptors in health and disease. This year, the conference is jointly organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), which held its first bi-annual meeting in 1998 and has convened in Europe, North America, and Asia. This is the first conference organized by FASEB and RRSH and will be held virtually.
The conference achieves significant cross-fertilization of ideas and in-depth discussions by gathering scientists and clinicians working in endocrinology, metabolism, cancer, reproduction, and development. This SRC, co-organized by two societies, is unique in this regard and offers exposure to scientific discoveries that often translate into more effective medical therapies.
Learn more
Organizers
Daniel E. Frigo, PhD
Associate Professor, Departments of Cancer Systems Imaging and Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA
Eric Prossnitz, PhDDistinguished Professor and Chief, Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico, and Maralyn S. Budke Endowed Chair in Cancer Chemical Biology and Therapeutics, UNM Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, USA
Zeynep Madak Erdogan, PhD
Associate Professor, Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, USA
Matthias Barton, MD
Professor of Cardiology, University of Zürich School of Medicine, Switzerland
Franck Mauvais-Jarvis, MD, PhDPrice Goldsmith Professor in Diabetes Research, Professor of Medicine and Pharmacology, Tulane University School of Medicine, Director, Tulane Center of Excellence in Sex-Based Biology & Medicine, and Staff Physician, Southeastern Louisiana Veterans Affairs Medical Center, New Orleans, USA
Keynote Lecture
Donald P. McDonnell, PhD
Glaxo-Wellcome Professor of Molecular Cancer Biology, Department of Pharmacology and Cancer Biology, Duke University, and Co-Director, Women's Cancer Program, Duke Cancer Institute
Email Sign Up
Sign up for emails to receive updates and information this conference.Sponsors
.png)
_Logo.png){kind=logo}
Funding for this conference was made possible [in part] by 1R13AI161942 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
